Markets:

Overview

News

Currencies

International

Treasuries

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

9.320 +0.160 (+1.75%)

Streaming Delayed Price Updated: 10:26 AM EDT, Mar 19, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

What's Going On With BioCryst Pharmaceuticals Stock? ↗

January 08, 2024

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) shares are trading higher Monday.

Via Benzinga

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

Where BioCryst Pharma Stands With Analysts ↗

November 20, 2023

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q3 2023 Earnings Call Transcript ↗

November 03, 2023

BCRX earnings call for the period ending September 30, 2023.

Via The Motley Fool

Topics Earnings

What 7 Analyst Ratings Have To Say About BioCryst Pharma ↗

September 25, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023 ↗

September 18, 2023

Via Benzinga

Analyst Expectations for BioCryst Pharma's Future ↗

May 04, 2023

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Soaring Today ↗

May 03, 2023

The biotech's Q1 earnings report contained a number of positives.

Via The Motley Fool

BioCryst Clocks 37.8% Revenue Growth In Q1 On Solid New Patient Growth ↗

May 03, 2023

Via Benzinga

3 Magnificent Growth Stocks to Buy on the Dip ↗

August 28, 2023

These three biotech stocks are attractive buys right now.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2023 ↗

August 04, 2023

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q2 2023 Earnings Call Transcript ↗

August 03, 2023

BCRX earnings call for the period ending June 30, 2023.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2023 ↗

July 13, 2023

Via Benzinga

Recap: BioCryst Pharma Q1 Earnings ↗

May 03, 2023

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q1 2023 Earnings Call Transcript ↗

May 03, 2023

BCRX earnings call for the period ending March 31, 2023.

Via The Motley Fool

Why Is BioCryst Pharmaceuticals (BCRX) Stock Down 8% Today? ↗

April 18, 2023

BioCryst Pharmaceuticals (BCRX) stock is slipping on Tuesday after the biotech company announced new funding to pay down debts.

Via InvestorPlace

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Shares of BioCryst Pharmaceuticals Jumped Today ↗

February 22, 2023

A day after the stock plummeted, it bounced back.

Via The Motley Fool

Analyst Sees Attractive Entry Opportunity After BioCryst's Pipeline Setback ↗

February 22, 2023

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Sinking Today ↗

February 21, 2023

Investors didn't like the drugmaker's Q4 update.

Via The Motley Fool

Biocryst Pharmaceuticals's Earnings Outlook ↗

February 20, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023 ↗

February 22, 2023

Via Benzinga

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 21, 2023

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

Via Benzinga

BioCryst Pharmaceuticals (BCRX) Q4 2022 Earnings Call Transcript ↗

February 21, 2023

BCRX earnings call for the period ending December 31, 2022.

Via The Motley Fool

Why BioCryst Pharmaceuticals Stock Is Sliding Today ↗

February 21, 2023

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Tuesday after the company reported worse-than-expected earnings results<

Via Benzinga

Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 09, 2023

Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.

Via Benzinga

BioCryst Pharmaceuticals Stock Is Tumbling: What's Going On? ↗

January 09, 2023

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday after the company announced preliminary fourth-quarter and full

Via Benzinga

TSLA Stock Price Prediction: What to Know as Analysts Slash Tesla Price Targets ↗

December 15, 2022

Tesla (TSLA) stock is in the news as price predictions continue to be a hot topic among traders after Elon Musk's Twitter purchase.

Via InvestorPlace

Why Is Getaround (GETR) Stock Up 6% Today? ↗

December 15, 2022

Getaround (GETR) stock is on the move Thursday with heavy trading despite a lack of recent news concerning the car-sharing service.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.